We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+9.79%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$215M
Cap. Flow
-$3.98M
Cap. Flow %
-0.15%
Top 10 Hldgs %
39.57%
Holding
443
New
37
Increased
128
Reduced
97
Closed
16

Top Buys

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$31.4M
2
NFLX icon
Netflix
NFLX
+$23.5M
3
SLB icon
SLB Ltd
SLB
+$21.9M
4
KO icon
Coca-Cola
KO
+$21.8M
5
SPOT icon
Spotify
SPOT
+$21M

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$50.2M
2
APTV icon
Aptiv
APTV
+$46.3M
3
PYPL icon
PayPal
PYPL
+$42.5M
4
CCI icon
Crown Castle
CCI
+$35.6M
5
BALL icon
Ball Corp
BALL
+$29.3M

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Industrials 15.84%
3 Communication Services 11.91%
4 Healthcare 11.29%
5 Financials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
126
Air Products & Chemicals
APD
$64.9B
$956K 0.04%
3,323
+925
+39% +$272K
BN icon
127
Brookfield
BN
$106B
$956K 0.04%
34,791
-243
-0.7% -$6.22K
PYPL icon
128
PayPal
PYPL
$49.3B
$956K 0.04%
3,279
-161,091
-98% -$42.5M
OTIS icon
129
Otis Worldwide
OTIS
$27.5B
$942K 0.04%
11,515
-1,000
-8% -$77K
NKE icon
130
Nike
NKE
$63B
$934K 0.04%
6,045
VNQ icon
131
Vanguard Real Estate ETF
VNQ
$39.2B
$926K 0.04%
9,093
+2,332
+34% +$231K
PFE icon
132
Pfizer
PFE
$142B
$923K 0.04%
23,576
+5,985
+34% +$233K
NVS icon
133
Novartis
NVS
$293B
$922K 0.04%
10,100
ROKU icon
134
Roku
ROKU
$21.7B
$921K 0.04%
2,005
+5
+0.3% +$1.77K
YETI icon
135
Yeti Holdings
YETI
$3.81B
$918K 0.04%
10,000
+5,000
+100% +$434K
VB icon
136
Vanguard Morningstar Small-Cap ETF
VB
$80.6B
$917K 0.04%
4,070
+835
+26% +$185K
HIT
137
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$916K 0.04%
8,000
TDOC icon
138
Teladoc Health
TDOC
$1.2B
$913K 0.04%
5,491
-165
-3% -$26.7K
GOOGL icon
139
Alphabet (Google) Class A
GOOGL
$4.57T
$901K 0.04%
7,380
+660
+10% +$77.1K
REGN icon
140
Regeneron Pharmaceuticals
REGN
$78.6B
$894K 0.03%
1,600
+100
+7% +$50.7K
ABNB icon
141
Airbnb
ABNB
$89.8B
$887K 0.03%
5,790
-325
-5% -$51K
UL icon
142
Unilever
UL
$138B
$884K 0.03%
13,428
+28
+0.2% +$1.86K
PLUG icon
143
Plug Power
PLUG
$2.9B
$866K 0.03%
25,315
-5,000
-16% -$145K
EXAS
144
DELISTED
Exact Sciences
EXAS
$862K 0.03%
+6,935
New +$828K
VSS icon
145
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
$857K 0.03%
6,278
+1,925
+44% +$261K
CPNG icon
146
Coupang
CPNG
$29.9B
$845K 0.03%
20,200
-19,800
-50% -$811K
BAB icon
147
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$843K 0.03%
25,392
+238
+0.9% +$7.76K
DHR icon
148
Danaher
DHR
$139B
$840K 0.03%
3,531
RIO icon
149
Rio Tinto
RIO
$155B
$839K 0.03%
10,000
CNH
150
CNH Industrial
CNH
$13.7B
$836K 0.03%
57,450

Similar funds

R.H. Bluestein & Co's Q2 2021 Portfolio in Review

As of Q2 2021, R.H. Bluestein & Co held 443 positions worth $2.58B, up 9.1% from $2.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

R.H. Bluestein & Co's Q2 2021 filing shows 37 new, 128 increased, 97 reduced and 16 closed positions. Its largest new stake was Estee Lauder: 103,700 shares worth $33M. The largest sale was Freeport-McMoran, an estimated $50.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Communication Services.

  • R.H. Bluestein & Co's largest Q2 2021 buy was Estee Lauder: 103,700 shares worth $33M.
  • R.H. Bluestein & Co added most to Netflix in Q2 2021, an estimated $23.5M increase.
  • R.H. Bluestein & Co's biggest Q2 2021 reduction was Freeport-McMoran, cutting an estimated $50.2M.
  • R.H. Bluestein & Co fully exited Warner Music in Q2 2021, selling an estimated $506K.
  • R.H. Bluestein & Co's ten largest holdings make up 40% of its $2.58B portfolio in Q2 2021.
  • R.H. Bluestein & Co opened 37 new positions and closed 16 in Q2 2021.
  • R.H. Bluestein & Co's portfolio value rose 9.1% quarter-over-quarter to $2.58B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2021, filed 13 Aug 2021.